Toggle Main Menu Toggle Search

Open Access padlockePrints

Comparison of provocative tests for unexplained syncope: isoprenaline and glyceryl trinitrate for diagnosing vasovagal syncope

Lookup NU author(s): Dr Laura Graham, Dr Janine Gray, Professor Rose Anne Kenny

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Aims To compare the sensitivity, specificity and adverse event profile of glyceryl trinitrate head-up tilt with isoprenaline head-up tilt in the diagnosis of vasovagal syncope in patients with unexplained syncope and healthy controls Methods and Results Forty-eight patients with unexplained syncope and negative passive head-up tilt at 70 degrees for 40 min, and 14 healthy controls underwent glyceryl trinitrate head-up tilt and isoprenaline head-up tilt (maximum dose 5 mug . min(-1)) one week apart in random order. Outcome measures were production of symptoms (syncope, pre-syncope) with development of hypotension. In those with negative passive head-up till, the sensitivity of glyceryl trinitrate for diagnosing vasovagal syncope was 48% and the specificity was 71%. Glyceryl trinitrate was well tolerated. Isoprenaline sensitivity was 21% with specificity 64%. Side-effects prevented completion of the test in 68%. Commonest adverse events were the development of hypertension or tachycardia and intolerable flushing or nausea. Conclusions Glyceryl trinitrate head-up tilt is as effective as isoprenaline head-up tilt as a provocative agent for vasovagal syncope and has a lower incidence of adverse events (C) 2001 The European Society of Cardiology.


Publication metadata

Author(s): Kenny RA; Gray JC; Graham LA

Publication type: Article

Publication status: Published

Journal: European Heart Journal

Year: 2001

Volume: 22

Issue: 6

Pages: 497-503

ISSN (print): 0195-668X

ISSN (electronic): 1522-9645

Publisher: Oxford University Press

URL: http://dx.doi.org/10.1053/euhj.1999.2007

DOI: 10.1053/euhj.1999.2007


Altmetrics

Altmetrics provided by Altmetric


Share